Carl Frieden, PhD, professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, has received a five-year, $1.56 million grant from the National Institute on Aging of the National Institutes of Health (NIH) for research titled “Alzheimer’s Disease: Defining the apoE-amyloid-beta interaction.”